Biotechnology (37) | Equity Distribution Agreements (37)

Browse by Company

Alector, Inc. (1)
Altimmune, Inc. (2)
Applied Therapeutics Inc. (1)
Aptevo Therapeutics Inc. (1)
Aptose Biosciences Inc. (2)
Aravive, Inc. (1)
ATOSSA GENETICS INC (2)
Biohaven Pharmaceutical Holding Co Ltd. (1)
bluebird bio, Inc. (1)
CANCER GENETICS, INC (1)
CATALYST BIOSCIENCES, INC. (1)
Cellectar Biosciences, Inc. (1)
Chelsea Worldwide Inc. (1)
CTD HOLDINGS INC (1)
Denali Therapeutics Inc. (1)
Frequency Therapeutics, Inc. (1)
HEMISPHERX BIOPHARMA INC (1)
iBio, Inc. (2)
Inhibikase Therapeutics, Inc. (1)
Isoray, Inc. (1)
Millendo Therapeutics, Inc. (1)
OncoCyte Corp (1)
PALATIN TECHNOLOGIES INC (1)
PhaseBio Pharmaceuticals Inc (1)
SELLAS Life Sciences Group, Inc. (1)
Sorrento Therapeutics, Inc. (1)
Stellar Biotechnologies, Inc. (3)
T2 Biosystems, Inc. (3)
XBiotech Inc. (1)

Recent Contracts

Equity Distribution Agreement, dated as of June 22, 2022, by and between bluebird bio, Inc. and Goldman Sachs & Co. LLC (bluebird bio, Inc., Filed With SEC on June 22, 2022)
Equity Distribution Agreement, dated May 16, 2022, by and between Inhibikase Therapeutics, Inc. and Piper Sandler & Co (Inhibikase Therapeutics, Inc., Filed With SEC on May 17, 2022)
Equity Distribution Agreement, dated April 14, 2022, by and among Clene Inc. and Canaccord Genuity LLC and Oppenheimer & Co. Inc (Chelsea Worldwide Inc., Filed With SEC on April 14, 2022)
Equity Distribution Agreement, dated April 8, 2022, by and between Vyant Bio, Inc. and Canaccord Genuity LLC (CANCER GENETICS, INC, Filed With SEC on April 11, 2022)
First Amendment to Equity Distribution Agreement, dated as of March 4, 2022, by and between Edesa Biotech, Inc. and RBC Capital Markets, LLC (Stellar Biotechnologies, Inc., Filed With SEC on March 4, 2022)
Equity Distribution Agreement between the Company and Goldman Sachs & Co. LLC, SVB Securities LLC and Cantor Fitzgerald & Co., dated as of February 28, 2022 (Denali Therapeutics Inc., Filed With SEC on February 28, 2022)
Equity Distribution Agreement, dated January 26, 2022, by and between the Company and Cowen and Company, LLC (Applied Therapeutics Inc., Filed With SEC on January 26, 2022)
Equity Distribution Agreement, dated as of December 10, 2021, between Frequency Therapeutics, Inc. and Oppenheimer & Co. Inc (Frequency Therapeutics, Inc., Filed With SEC on December 10, 2021)
Equity Distribution Agreement, dated as of November 22, 2021, by and between Edesa Biotech, Inc. and RBC Capital Markets, LLC (Stellar Biotechnologies, Inc., Filed With SEC on November 22, 2021)
Equity Distribution Agreement, dated November 10, 2021 by and between PhaseBio Pharmaceuticals, Inc. and William Blair & Company, L.L.C (PhaseBio Pharmaceuticals Inc, Filed With SEC on November 10, 2021)